Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
34.44B
Market cap34.44B
Price-Earnings ratio
26.87
Price-Earnings ratio26.87
Dividend yield
0.83%
Dividend yield0.83%
Average volume
1.86M
Average volume1.86M
High today
High today
Low today
Low today
Open price
$119.77
Open price$119.77
Volume
0.00
Volume0.00
52 Week high
$160.27
52 Week high$160.27
52 Week low
$99.12
52 Week low$99.12

Stock Snapshot

As of today, Agilent(A) shares are valued at $121.87. The company's market cap stands at 34.44B, with a P/E ratio of 26.87 and a dividend yield of 82.5%.

On 2026-04-20, Agilent(A) shares started trading at $119.77, with intraday highs of — and lows of —.

Trading volume for Agilent(A) stock has reached 0, versus its average volume of 1.86M.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $99.12.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $99.12.

A News

Simply Wall St 3d
Is Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative?

In late March 2026, Agilent Technologies announced that Senior Vice President, Chief Legal Officer and Secretary Bret DiMarco will step down once a successor is...

Is Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative?
TipRanks 5d
Agilent showcases cancer research solutions at AACR 2026

Agilent (A) Technologies will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the Am...

Simply Wall St 5d
Agilent Technologies Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Agilent Technologies (A) is back in focus after two contrasting developments: the Supreme Court left rulings invalidating its CRISPR related patents in place, a...

Agilent Technologies Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Analyst ratings

82%

of 22 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More A News

TipRanks 6d
Agilent price target lowered to $140 from $150 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on Agilent (A) to $140 from $150 and keeps an Overweight rating on the shares. The firm adjusted t...

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.